In our study, we investigated the concentration of extracellular matrix compounds, explicitly evaluating the levels of fibronectin, laminin, and collagen IV in plasma, urine, and renal cancer tissue (Table 3). The gene discussed is LAMB2; the disease is renal carcinoma.